Results 1–1 of 1 for attain - abatacept trial in treatment of anti-tnf inadequate responders.
  • ATTAIN - ABATACEPT TRIAL IN TREATMENT OF ANTI-TNF INADEQUATE RESPONDERS
    Bristol-Myers Squibb Company
    ATTAIN - ABATACEPT TRIAL IN TREATMENT OF ANTI-TNF INADEQUATE RESPONDERS